Company / R&D Expense
Merit Medical Systems, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$97.4M
FY2025
5-year range
$65.6M / $97.4M
FY2021-FY2025
Trend
+11.3%
vs FY2024
Sector context
#59 of 110
Health Care
What the data says
At $97M, Merit Medical Systems, Inc.'s r&d expense ranks #59 of 110 in the Health Care sector. R&D Expense has increased for 9 consecutive years, from $37M in FY2016 to $97M in FY2025.
Based on SEC 10-K filings.
$97M in FY2025 with a 5-year CAGR of +10.3%.
Improved from $83M to $97M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#59 of 110 in Health CareTop 54% of 110This company $97.4M Sector average $298.2M
▼
-67.4% below sector average
Key checks
Key Insights
- Merit Medical Systems, Inc.'s r&d expense has grown for 9 consecutive years.
- 5-year CAGR of +10.3%, indicating consistent growth.
- In FY2025, r&d expense increased 11.3% year-over-year.
- Ranks #59 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.4M | +11.3% |
| FY2024 | $87.5M | +5.7% |
| FY2023 | $82.7M | +9.6% |
| FY2022 | $75.5M | +15.1% |
| FY2021 | $65.6M | +10.2% |
| FY2020 | $59.5M | +15.8% |
| FY2019 | $51.4M | +13.7% |
| FY2018 | $45.2M | +10.8% |
| FY2017 | $40.8M | +11.4% |
| FY2016 | $36.6M | +8.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026